Sulfonamides (heterogenic)

SULOFONAMIDES

No definition available.

Endpoint definition

FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC A10BC

-

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

-

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

-

diagram downward connector

Include endpoints None

-

diagram downward connector
SULOFONAMIDES

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to Sulfonamides (heterogenic) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

None

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals - - -
Unadjusted prevalence (%) - - -
Mean age at first event (years) - - -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: SULOFONAMIDES – Sulfonamides (heterogenic)
GWS hits:

Survival analyses between endpoints

Plot

before Sulfonamides (heterogenic)
after Sulfonamides (heterogenic)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Sulfonamides (heterogenic)